Home Journals Articles Updates About
CN
image
收藏切换
Research Progress of Xiebai Powder（泻白散）and Prediction Analysis of Quality Markers（Q-Markers）
收藏切换
Fangfang QIN1, Qin QIU1, Hongxing WEI1, Pengfei LI1, Chunping QIN1, Huiqing MO1, Zujie QIN1, 2, Jiangcun WEI1, 2, Hanshen ZHEN1
Chinese Archives of Traditional Chinese Medicine | 2025, 43(11) : 155 - 161
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2025, 43(11): 155-161
• Target on National Project •
Research Progress of Xiebai Powder（泻白散）and Prediction Analysis of Quality Markers（Q-Markers）
Full
Fangfang QIN1, Qin QIU1, Hongxing WEI1, Pengfei LI1, Chunping QIN1, Huiqing MO1, Zujie QIN1, 2, Jiangcun WEI1, 2, Hanshen ZHEN1
Affiliations
  • 1.Guangxi University of Chinese Medicine，Nanning530000，Guangxi，China
  • 2.Guangxi International Zhuang Medical Hospital，Nanning 530000，Guangxi，China
Published: 2025-11-10 doi: 10.13193/j.issn.1673-7717.2025.11.031
Outline
收藏切换

The classic prescription Xiebai Powder（泻白散）was first recorded in QIAN Yi's Xiao'er Yaozheng Zhijue in the Northern Song Dynasty. It has the effects of clearing lung heat，relieving cough and relieving asthma. The chemical components of the whole prescription are diverse，mainly organic acids，flavonoids and alkaloids. Xiebai Powder has rich pharmacological effects such as eliminating phlegm，relieving cough and asthma，anti-inflammation，antipyretic and analgesic effect and anti-pathogenic microorganisms. Modern clinical treatment is mainly used to treat respiratory diseases such as pneumonia，chronic bronchitis，cough and asthma in children. It can also be used to treat skin diseases，lung cancer，rhinitis，functional constipation in children and other diseases. At the same time，based on the“five principles”of quality markers，the Quality markers（Q-Markers）of Xiebai Powder was predicted and analyzed. The results showed that morin C，mulberroside A，esculin，kaempferol，quercetin，glycyrrhizic acid，glycyrrhetinic acid and liquiritin were the Q-Markers of Xiebai Powder，in order to provide a more comprehensive reference for the establishment of a more scientific quality evaluation standard system of Xiebai Powder.

Xiebai Powder（泻白散）  /  chemical constituents  /  pharmacological effects  /  clinical application  /  quality markers
覃芳芳, 丘琴, 韦红杏, 李鹏飞, 覃春萍, 莫惠晴, 秦祖杰, 魏江存, 甄汉深. 泻白散的研究进展及质量标志物（Q-Marker）预测分析. 中华中医药学刊, 2025 , 43 (11) : 155 -161 . DOI: 10.13193/j.issn.1673-7717.2025.11.031
Fangfang QIN, Qin QIU, Hongxing WEI, Pengfei LI, Chunping QIN, Huiqing MO, Zujie QIN, Jiangcun WEI, Hanshen ZHEN. Research Progress of Xiebai Powder（泻白散）and Prediction Analysis of Quality Markers（Q-Markers）[J]. Chinese Archives of Traditional Chinese Medicine, 2025 , 43 (11) : 155 -161 . DOI: 10.13193/j.issn.1673-7717.2025.11.031
Appendix
Less
Year 2025 volume 43 Issue 11
41
19
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2025.11.031
  • Online Date：2026-10-30
  • Published：2025-11-10
Article Data
Affiliations
History
Funding
Affiliations
    1.Guangxi University of Chinese Medicine，Nanning530000，Guangxi，China
    2.Guangxi International Zhuang Medical Hospital，Nanning 530000，Guangxi，China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2025.11.031
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House